Literature DB >> 9004095

The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence.

P K Whelton1, T V Perneger, J He, M J Klag.   

Abstract

The aim of the paper is to examine the relationship between blood pressure (BP) and renal disease with an overview of observational and experimental investigations, with the emphasis on studies that provide data obtained in unselected population samples. We have found an increasing body of evidence from cross-sectional, case-control, prospective, and experimental studies that indicate BP is an important, independent predictor of both increased relative and attributable risk of renal insufficiency and end-stage renal disease. The relationship between BP and subsequent renal disease appears to be positive and continuous throughout the entire range of BP. Furthermore, the data indicate that elevations in systolic BP (SBP) are stronger predictors of risk compared to corresponding increases in diastolic BP (DBP). Clinical trials experience suggests that reduction in BP decreases the risk of subsequent renal disease. Ongoing trials should help to clarify issues related to choice of antihypertensive therapy and optimal goals for reduction of BP in order to prevent renal disease.

Entities:  

Mesh:

Year:  1996        PMID: 9004095

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  15 in total

1.  Reducing the public health burden from elevated blood pressure levels in the United States by lowering intake of dietary sodium.

Authors:  Stephen Havas; Edward J Roccella; Claude Lenfant
Journal:  Am J Public Health       Date:  2004-01       Impact factor: 9.308

Review 2.  Risks of rapid decline renal function in patients with type 2 diabetes.

Authors:  Yi-Jing Sheen; Wayne Hh Sheu
Journal:  World J Diabetes       Date:  2014-12-15

Review 3.  Sex and gender differences in hypertensive kidney injury.

Authors:  Jennifer C Sullivan; Ellen E Gillis
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-19

4.  Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions.

Authors:  Mehmet Kanbay; Adem Ozkara; Yusuf Selcoki; Bunyamin Isik; Faruk Turgut; Nuket Bavbek; Ebru Uz; Ali Akcay; Ramazan Yigitoglu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2007-08-15       Impact factor: 2.370

Review 5.  New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies.

Authors:  Roy D Bloom; Michael F Crutchlow
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

6.  Metabolic syndrome and renal injury.

Authors:  Yi-Jing Sheen; Wayne Huey-Herng Sheu
Journal:  Cardiol Res Pract       Date:  2011-03-13       Impact factor: 1.866

7.  Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad.

Authors:  Mário Raimundo; José António Lopes
Journal:  Cardiol Res Pract       Date:  2011-02-20       Impact factor: 1.866

Review 8.  Crosstalk between the unfolded protein response and NF-κB-mediated inflammation in the progression of chronic kidney disease.

Authors:  Zahraa Mohammed-Ali; Gaile L Cruz; Jeffrey G Dickhout
Journal:  J Immunol Res       Date:  2015-04-21       Impact factor: 4.818

9.  Ethnic differences in the association between blood pressure components and chronic kidney disease in middle aged and older Asian adults.

Authors:  Charumathi Sabanayagam; Boon Wee Teo; E Shyong Tai; Tazeen H Jafar; Tien Yin Wong
Journal:  BMC Nephrol       Date:  2013-04-17       Impact factor: 2.388

10.  Interaction Effects of the Leu162Val PPAR α and Pro12Ala PPAR γ 2 Gene Variants with Renal Function in Metabolic Syndrome Population.

Authors:  Sarraj Mohamed Youssef; Najah Mohamed; Slimani Afef; Ben Hamda Khaldoun; Neffati Fadoua; Najjar Mohamed Fadhel; Slimane Mohamed Naceur
Journal:  PPAR Res       Date:  2013-04-04       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.